Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
Public ClinicalTrials.gov record NCT01514149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of 17 Weeks of Weekly Injections of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy
Study identification
- NCT ID
- NCT01514149
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- ConjuChem
- Industry
- Enrollment
- 73 participants
Conditions and interventions
Conditions
Interventions
- CJC-1134-PC Injection Drug
- Weekly placebo for CJC-1134-PC Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2011
- Primary completion
- Apr 30, 2012
- Completion
- Feb 28, 2013
- Last update posted
- Jul 18, 2017
2011 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Inglewood | California | 90301 | — |
| Research Site | Tarzana | California | 91356 | — |
| Research Site | Ventura | California | 93003 | — |
| Research Site | Wellington | Florida | 33414 | — |
| Research Site | Idaho Falls | Idaho | 83404 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Brighton | Massachusetts | 02135 | — |
| Research Site | Greensboro | North Carolina | 27405 | — |
| Research Site | Eugene | Oregon | 97401 | — |
| Research Site | Altoona | Pennsylvania | 16602 | — |
| Research Site | East Providence | Rhode Island | 02915 | — |
| Research Site | Charleston | South Carolina | 29407 | — |
| Research Site | Taylors | South Carolina | 29687 | — |
| Research Site | Austin | Texas | 78758 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | San Antonio | Texas | 78249 | — |
| Research Site | Salt Lake City | Utah | 84107 | — |
| Research Site | Henrico | Virginia | 23233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01514149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2017 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01514149 live on ClinicalTrials.gov.